505 related articles for article (PubMed ID: 10861091)
1. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
2. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
[TBL] [Abstract][Full Text] [Related]
3. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
4. Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells.
Duchosal MA; Mauray S; Rüegg M; Trouillet P; Vallet V; Aarden L; Tissot JD; Schapira M
Cell Immunol; 2001 Jul; 211(1):8-20. PubMed ID: 11585383
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.
Dierksheide JE; Baiocchi RA; Ferketich AK; Roychowdhury S; Pelletier RP; Eisenbeis CF; Caligiuri MA; VanBuskirk AM
Blood; 2005 Feb; 105(4):1558-65. PubMed ID: 15498860
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.
Baiocchi RA; Ward JS; Carrodeguas L; Eisenbeis CF; Peng R; Roychowdhury S; Vourganti S; Sekula T; O'Brien M; Moeschberger M; Caligiuri MA
J Clin Invest; 2001 Sep; 108(6):887-94. PubMed ID: 11560958
[TBL] [Abstract][Full Text] [Related]
7. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
8. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
[TBL] [Abstract][Full Text] [Related]
9. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
[TBL] [Abstract][Full Text] [Related]
10. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
12. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
13. A novel mouse xenotransplantation model of EBV-T/NK-LPD and the application of the mouse model.
Imadome K
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):433-41. PubMed ID: 24390103
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.
Cao T; Leroux-Roels G
Clin Exp Immunol; 2000 Oct; 122(1):117-23. PubMed ID: 11012627
[TBL] [Abstract][Full Text] [Related]
15. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
Tary-Lehmann M; Lehmann PV; Schols D; Roncarolo MG; Saxon A
J Exp Med; 1994 Nov; 180(5):1817-27. PubMed ID: 7964463
[TBL] [Abstract][Full Text] [Related]
16. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
[TBL] [Abstract][Full Text] [Related]
17. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
Johannessen I; Bieleski L; Urquhart G; Watson SL; Wingate P; Haque T; Crawford DH
J Med Virol; 2011 Sep; 83(9):1585-96. PubMed ID: 21739450
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice.
Foote JB; Kabir FM; Graff EC; Cattley RC; DeInnocentes P; Smith BF; Bird RC
Vet Immunol Immunopathol; 2014 Feb; 157(3-4):131-41. PubMed ID: 24368085
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice.
Lacerda JF; O'Reilly RJ
Ann Oncol; 1997; 8 Suppl 2():137-40. PubMed ID: 9209657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
